Facebook
Twitter
LinkedIn
Forward
Essentials of Oncology and Transplant Management for the Health Care Team
These materials are intended only for those that attended the Essentials of Oncology and Transplant Management conference April 8–9, 2025, in Scottsdale, AZ.
Activity description
The Essentials of Oncology and Transplant Management is designed for all who are interested in learning best practices for optimal patient and/or benefit management in the fields of transplant medicine and oncology.
Provided by
This activity is provided by Optum Health Education.
Commercial support
There was no commercial support received for this activity.
Target Audience
This activity has been designed to meet the educational needs of case managers, coders, dietitians, dietetic technicians, managed care nurses, nurses, nurse practitioners, pharmacists, pharmacy technicians, PAs, physicians, psychologists, social workers, transplant coordinators and other health care professionals.
Learning Objectives
As a result of attending this conference, learners should be able to:
- Evaluate the indications, benefits, and risks of pancreas transplantation in diabetic patients to improve glycemic control and quality of life.
- Discuss the criteria for selecting patients for living-donor liver transplant (LDLT) in metastatic colorectal cancer (mCRC) and the outcomes of recent studies to optimize patient selection and management.
- Identify common post-lung-transplant complications and evidence-based management strategies to improve patient outcomes.
- Discuss the transformative innovations in transplantation technology, focusing on machine perfusion for liver transplants and enhanced recovery techniques in kidney transplants.
- Evaluate current prophylaxis and treatment strategies for CMV and BK infections in solid-organ transplant recipients to manage antiviral resistance and improve patient care.
- Summarize the key updates and changes in the continuous distribution system for organ allocation to understand their impact on transplant outcomes.
- Explain recent advancements in the treatment of acute myeloid leukemia (AML) to enhance patient outcomes and quality of life.
- Discuss the latest therapeutic strategies and multidisciplinary approaches in managing graft-versus-host disease (GVHD) to improve patient care.
- Identify the challenges and emerging applications of CAR T-cell therapy to optimize its use in clinical practice.
- Summarize recent advancements in the diagnosis and treatment of multiple myeloma to improve patient outcomes.
- Discuss the latest staging, diagnostic processes and treatment advancements in colon cancer to enhance patient care.
- Describe the current state of melanoma, including epidemiology, traditional and advanced treatment strategies and the integration of novel therapies with established practices.
Faculty
- Lizamarie Bachier-Rodriguez, MD, Northside Hospital
- Elizabeth Budde, MD, PhD, City of Hope
- Matthew Cooper, MD, Medical College of Wisconsin
- Roberto Hernandez-Alejandro, MD, University of Rochester
- Lisa M. Latts, MD, MSPH, MBA, FACP, Optum Health Clinical Excellence
- Christopher Lieu MD, University of Colorado Medicine
- Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center
- Jennifer Milton, MBA, BSN, UT Health San Antonio
- Justin Moser, MD, HonorHealth Research Institute
- Satish Nadig, MD, PhD, FACS, Northwestern Medicine
- Nathan Punwani, MD, Mayo Clinic
- Melissa Roberts, MSN, RN, UW Health Transplant Center
- Sarah L. Sampsel, MPH, American Society of Nephrology
- Fernanda Silveira, MD, MS, FIDSA, FAST, UPMC
- Robin Tenny, RN, MAOM, CHB, Liver Transplant Recipient
- Rajat Walia, MD, St. Joseph’s Hospital and Medical Center
Planners
Elizabeth Albert, MD
Clinical Activity Manager
Optum Health Education
Anthony Bonagura, MD
Senior National Medical Director, Transplant and CHD
Optum
Matthew Cooper, MD
Mark B. Adams Chair in Transplant Surgery
Chief, Division of Transplant Surgery
Director, Solid Organ Transplant Service Line
Froedtert Memorial Lutheran Hospital;
Director, Solid Organ Transplantation
Children’s Wisconsin;
Tenured Professor of Surgery
Medical College of Wisconsin
Sara Fleszar, PharmD, BCOP
Senior Clinical Pharmacist
Optum Health Solutions
Rebecca Gleason, RN, CCM
Clinical Activity Manager
Optum Health Education
Katie L. Lo Coco RN, BSN, CCTC, CCM
Clinical Operations Manager for Transplant Solutions M&R
Optum Health
Navneet Majhail, MD, MS, FASTCT
Physician-in-Chief of Blood Cancers
Director, Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial
Sarah Cannon Cancer Institute
Dirk Slaker, MD
Senior National Medical Director, Transplant
Optum
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, OptumHealth Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
Financial Relationship Key
A-Advisory Board
CT-Clinical Trial
C-Consultant
E-Employee
G- Grant/Research Support or Funding
I-Stocks and Other Ownership Interests
S-Speakers’ Bureau
O-Other Financial or Material Support
- Lizamarie Bachier-Rodriguez: Kite Gilead (S)
- Elizabeth Budde: Bristol Myers Squibb, Crispr Therapeutics, Kite Pharma (A)
- Roberto Hernandez-Alejandro: HistoSonics (I)
- Christopher Lieu: Genentech, Sanofi, Janssen (G); Amgen, Flatiron Health (C)
- Sham Mailankody: Bristol Myers Squibb, Janssen, Takeda, Fate Therapeutics, Caribou Therapeutics, Allogene Therapeutics (G); Bristol Myers Squibb, AbbVie, ArcellX, Sanofi, Legend Therapeutics, Janssen (C)
- Justin Moser, MD: Caris Life Sciences; Genome Insight, Imaging Endpoints, Incyte, Iovance Biotherapeutics, IQVIA, Novotech, Pfizer, Red Arrow Therapeutics, Replimune, Thirona Bio, Vilya, Werewolf Therapeutics (C/A); Caris Life Sciences, Immunocore, Castle Biosciences (S)
- Satish Nadig: Pandorum Technologies (G, I)
- Fernanda Silveira: Ansun, GSK (G); Eurofins Viracor (A)
- Rajat Walia: Grifols, Takeda, Boehringer Ingelheim, Astellas (S)
All relevant financial relationships have been mitigated.
The remaining faculty and planners have no financial relationships to disclose.
Maximum CE credits available: 12.75
Thursday, April 8 — Up to 7.25 CE Credits
Friday, April 9 — Up to 5.50 CE Credits
Accreditation statement
 | In support of improving patient care, this activity has been planned and implemented by Optum Health Education. Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Credit designation statements
 | This activity was planned by and for the health care team, and learners will receive 12.75 Interprofessional Continuing Education (IPCE) credits for learning and change. |
Physicians
Optum Health Education designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs
The American Academy of PAs (AAPA) accepts credit from organizations accredited by the ACCME.
AAPC-certified coders
AAPC will honor 1-for-1 CEUs for any live event offering CME credit or AMA PRA Category 1 Credit. A certificate of attendance or completion is necessary to show participation. The certificate will give the total CMEs possible for the offering. Physicians are advised to claim only the actual hours that they were present during the education. We ask that AAPC-certified members abide by this request also. One hour of instruction is worth one CEU.
Pharmacists/Pharmacy technicians
This activity is approved for 12.75 contact hours (1.275 CEUs) in states that recognize ACPE.
Attending the full program will earn 12.75contact hours (1.275 CEUs).
Unique activity number: JA0007123-0000-25-011-L01-P/T
Nurses
The participant will be awarded up to 12.75 contact hours of credit for attendance and completion of supplemental materials.
Nurse practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Case managers
The Commission for Case Manager Certification has approved this program for a maximum of 12.75 clock hours for Certified Case Managers (CCM).
Dietitians
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit=One CPEU).
If the ac
tivity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour=1 CPEU).
RD's and DTRs are to select activity type 102 in their Activity Log. Performance indicator selection is at the learner's discretion.
Managed Care Nurses
This activity has been approved for a maximum of 12.75 clock hours for Certified Managed Care Nurse (CMCN) recertification by the American Board of Managed Care Nursing (ABMCN).
Psychologists
Optum Health Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. Optum Health Education maintains responsibility for this program. 12.75 CE hour.
Social workers
| As a Jointly Accredited Organization, Optum Health Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Optum Health Education maintains responsibility for this course. Social workers completing this course receive up to12.75 live continuing education credits. |
Transplant coordinators, transplant nurses, procurement transplant coordinators
The American Board for Transplant Certification (ABTC) has approved this educational offering for up to 12.75 Category 1 Continuing Education Points for Transplant Certification (CEPTCs).
ILNA coding
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.
Click here for a list of available ILNA points by Session. Total ILNA points available: 6.25
Disclaimer: “ONCC review is only for designating content to be used for ILNA points and is not for CNE accreditation. CNE programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing CE to be used for recertification by ONCC. If the CNE provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification or ILNA categories may be used in relation to the program.”
Attendance
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
Available Credit
- 12.75 AAPC - Coders
- 12.75 ABTC - Transplant Coordinators
- 12.75 ACPE - Pharmacists
- 12.75 ACPE - Pharmacy Technicians
- 12.75 AMA - Physicians
- 12.75 ANCC - Nurses
- 12.75 APA - Psychologists
- 12.75 Attendance - General Attendance
- 12.75 CCMC - General - Case Managers
- 12.75 CDR - Dietitians
- 12.75 CMCN - Certified Managed Care Nurse
These materials are intended only for those that attended the Essentials of Oncology and Transplant Management conference April 8–9, 2025, in Scottsdale, AZ.
Instructions to claim credit
To claim credit you must be logged into your Optum Health Education account.
- To Log In, scroll to the top of this page.
- If you DO have an optumhealtheducation.com account, click Log in at the top of the page, enter your account information and click LOG IN
- If you DO NOT have an optumhealtheducation.com account, click Create account at the top of the page and enter your information. Click CREATE ACCOUNT
- Once logged in: under the REGISTER tab, click CONTINUE
- In the Activity Progress box on the left, click the down arrow and then Start under Evaluation
- Complete the Evaluation; follow the prompts at the bottom of the screen to submit and continue to the application for credit, and automatic certificate generation